Autopsy report · NCT03888287

Parkinson's Disease Inpatient Clinical Knowledge and Management

“Study was put on hold due to COVID and never reopened”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 5 months before it stopped.
• 477 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hackensack Meridian Health

Sponsor type

University, hospital or other

Conditions

Parkinson Disease

Interventions

Watch Rx system; Parkinson's Disease Inpatient Clinical Knowledge and Management Program

Participants

477

Sites

1

Countries

United States

Trials that died the same way

• A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)
  “Study initially suspended due to COVID-19 Pandemic- treatment stopped - never reopened to recruitment..” (76% match in meaning)
• Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers
  “Study terminated due to COVID” (75% match in meaning)
• New Formulations of Propafenone to Treat Atrial Fibrillation
  “Study halted/terminated prematurely due to COVID.” (75% match in meaning)
• MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
  “COVID arm of study completed, paused while funding sought” (72% match in meaning)
• Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty
  “Was placed on hold due to the COVID-19 pandemic, and then PI decided not to continue study.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.